ALK and lung adenocarcinoma: Patient#B was a 53-year-old male, current smoker, with a lung adenocarcinoma TTF1+ PDL1 0% without EGFR, KRAS, or BRAF mutation or ALK and ROS1 translocation but STK11 mutation.